Edition:
United States

UDG Healthcare PLC (UDG.L)

UDG.L on London Stock Exchange

885.00GBp
15 Dec 2017
Change (% chg)

4.50 (+0.51%)
Prev Close
880.50
Open
877.50
Day's High
886.00
Day's Low
875.50
Volume
1,061,767
Avg. Vol
656,821
52-wk High
963.00
52-wk Low
632.50

Latest Key Developments (Source: Significant Developments)

UDG Healthcare reports ‍FY net revenue growth of 12 pct to $1,028.5 mln​
Tuesday, 28 Nov 2017 02:27am EST 

Nov 28 (Reuters) - UDG Healthcare Plc ::SAYS ‍FY NET REVENUE GROWTH OF 12% (16% ON A CONSTANT CURRENCY BASIS) TO $1,028.5 MILLION.​.‍ADJUSTED DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS INCREASED BY 17%​.‍NET REVENUE GROWTH OF 12% (16% ON A CONSTANT CURRENCY BASIS) TO $1,028.5 MILLION​.SAYS ‍HAS NOW REDEPLOYED OVER TWO THIRDS OF NET PROCEEDS FROM 2016 SALE OF UNITED DRUG SUPPLY CHAIN BUSINESS TO MCKESSON​.PROPOSED 7.5% INCREASE IN FINAL DIVIDEND TO $9.72C PER SHARE, YIELDING A FULL YEAR DIVIDEND INCREASE OF 7% TO $13.3C PER SHARE​.‍UDG HEALTHCARE CHIEF FINANCIAL OFFICER, ALAN RALPH, HAS INFORMED BOARD THAT HE INTENDS TO RETIRE FROM HIS ROLE BY END OF 2018​.‍GROUP EXPECTS ORGANIC GROWTH TO ACCELERATE DURING SECOND HALF OF YEAR​.FY ‍ADJUSTED OPERATING PROFIT GROWTH OF 12% (17% ON A CONSTANT CURRENCY BASIS) TO $129.3 MILLION​.  Full Article

UDG Healthcare ‍announces acquisition of US-based healthcare communications agency​
Thursday, 14 Sep 2017 02:00am EDT 

Sept 14 (Reuters) - UDG HEALTHCARE PLC ::‍ANNOUNCES ACQUISITION OF US-BASED HEALTHCARE COMMUNICATIONS AGENCY FOR UP TO $75.8M​.‍MICROMASS IS BEING ACQUIRED FOR AN INITIAL CONSIDERATION OF $63.8 MILLION, WITH AN ADDITIONAL CONSIDERATION OF UP TO $12 MILLION PAYABLE OVER NEXT THREE YEARS​.  Full Article

UDG Healthcare says Q3 revenue, profit ahead of last year
Thursday, 3 Aug 2017 02:05am EDT 

Aug 3 (Reuters) - UDG HEALTHCARE PLC :Q3 REVENUE AND ADJUSTED PROFIT BEFORE TAX AHEAD OF SAME QUARTER LAST YEAR​.‍GROUP REVENUE AND ADJUSTED PROFIT BEFORE TAX FOR NINE MONTHS TO 30 JUNE 2017 ARE IN LINE WITH EXPECTATIONS AND WELL AHEAD OF PRIOR YEAR​.  Full Article

UDG Healthcare acquires Cambridge Biomarketing
Monday, 17 Jul 2017 02:23am EDT 

July 17 (Reuters) - UDG Healthcare Plc ::Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln.Cambridge Biomarketing is being acquired for an initial consideration of $30 mln, with additional consideration of up to $5 mln .  Full Article

UDG Healthcare ‍acquires Vynamic for up to $32 mln
Wednesday, 12 Jul 2017 02:00am EDT 

July 12 (Reuters) - Udg Healthcare Plc :‍Acquisition of Vynamic Llc, a US-based healthcare industry management consulting firm, for total consideration of up to $32 million​.Says ‍Vynamic is being acquired for an initial consideration of $22 million​.Says ‍additional consideration of up to $10 million payable over next three years, based on achievement of agreed profit targets​.Says ‍business has been acquired for an upfront multiple of c. 7X ebit​.‍Also received competition approval for acquisition of Sellxpert Gmbh for a total potential consideration of up to $14.4 million​.  Full Article

UDG Healthcare appoints Jez Moulding as group COO
Wednesday, 12 Apr 2017 02:00am EDT 

UDG Healthcare Plc :Appoints Jez Moulding as group chief operating officer and executive vice president of Ashfield.  Full Article

UDG Healthcare division Sharp expands capacity in the US, UK
Monday, 3 Apr 2017 02:00am EDT 

UDG Healthcare Plc :Sharp Packaging Services, a division of UDG Healthcare Plc, announces capacity expansion in US and UK.  Full Article

UDS Healthcare says has made a good start to financial year
Tuesday, 7 Feb 2017 02:05am EST 

UDG Healthcare Plc : 1St quarter trading update . Good start to year and full year guidance issued . Group has made a good start to financial year with operating profits for quarter to 31 december 2016 well ahead of same quarter last year . Performance has been driven by continued good underlying growth and impact of acquisitions . As a result of fall in value of sterling, reported profit growth was moderated by translation of our sterling profits into us dollars. .Expects constant currency adjusted diluted eps 1 for year to 30 sept 2017 to be between 13% and 16% ahead of last year's continuing group eps of us$ 31.8c (euro: 28.6c)..  Full Article

UDG Healthcare says Q3 revenue ahead of same period last year
Thursday, 4 Aug 2016 02:00am EDT 

UDG Healthcare Plc : Trading performance for quarter to 30 June 2016 has been good with group revenues and adjusted operating profits ahead of same period last year . Board has decided that from start of its next FY, 1 October 2016, group will present its financial results in us dollars .Reiterates FY market guidance of 6-8 pct adjusted diluted EPS growth for continuing group on a constant currency basis.  Full Article

UK's CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe
Wednesday, 29 Jun 2016 10:27am EDT 

Competition and Markets Authority(CMA):UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of MASTA and Sangers to a Phase 2 investigation..  Full Article

UPDATE 1-UDG Healthcare CFO to retire; profit jumps 17 pct

Nov 28 UDG Healthcare reported a 17 percent increase in full-year earnings on Tuesday, driven mainly by acquisitions, and said Chief Financial Officer Alan Ralph would retire by the end of 2018.

No consensus analysis data available.